InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,930.91
(
2.56%
)
US TECH 100
20,229.04
(
2.75%
)
Dow Jones
43,731.64
(
3.58%
)
Brent Oil
75.10
(
-0.39%
)
Bitcoin
75,846.51
(
9.42%
)
Post# of 6451
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

urche

Send PM Follow Ignore
Followers 7
Posts 996
Boards Moderated 0
Alias Born 10/06/2004

urche

Re: None

Monday, 04/30/2007 6:44:10 AM

Monday, April 30, 2007 6:44:10 AM

Post# of 6451
News is out---Go back to bed

The PR is out, a few hours ahead of schedule.

Cobalis Expects to Report Phase III Top-Line Results in May
Monday April 30, 6:36 am ET

IRVINE, Calif.--(BUSINESS WIRE)--Cobalis Corp. (OTC BB: CLSC - News), a pharmaceutical development company specializing in anti-allergy medications, today announced it has been informed by its independent contract research organization that it would need more time to combine Cobalis' three locked data bases into a single database before un-blinding and conducting the statistical analysis required to generate top-line results for Cobalis' twin pivotal Phase III Clinical Trials of PreHistin(TM) in seasonal allergic rhinitis. The Company anticipates reporting its top-line results later in May.

Yawn.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up